Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-06-10 to 2022-07-05
Current total value of award: $42579.6
Description: 4557610545!TYSABRI 300 MG/15 ML VIAL 15ML